Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 2.060
+0.070 (3.52%)
At close: Aug 26, 2026
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €556.5 million as of August 26, 2026. Its market cap has increased by 40.13% in one year.
Market Cap
556.50M
Enterprise Value
698.90M
Revenue
102.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.06
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 556.50M, a decrease of -33.23%. That is a compound annual growth rate of -4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 556.50M | 23.37% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.33B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 22.04M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 225.65K |